Reprogramming of immune cells enhances effects of radiotherapy in preclinical models of brain cancer

A new study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the invariable recurrence of the aggressive brain cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *